Event

Journal Club - PSI’s Special Interest Groups (SIGs)

Add to:

For this special edition, we invited members from the PSI Special Interest Groups (SIGs), to present their work. Helena Geys from the toxicology SIG presented on the statistical methods used in toxicology studies, and Martin Jenkins from the biomarker SIG, presented a statistician's perspective of biomarkers in drug development.

CHAIR: Graham Healey, Oncimmune Ltd

Toxicology SIG

Speaker: Helena Geys, Janssen Pharmaceutica and Philip Jarvis, AstraZeneca
An assessment of the statistical methods used to analyse toxicology studies
Co-authors: Jim Saul, Mike Aylott, Simon Bate and John Sherington;
Pharmaceutical Statistics, Volume 10, Issue 6, Pages 477-484, November/December 2011
Abstract | Paper+ | Slides

Biomarker SIG

Speaker: Martin Jenkins, AstraZeneca and Chris Harbron, AstraZeneca
A statistician's perspective on biomarkers in drug development
Co-authors: Aiden Flynn, Trevor Smart, Tony Sabin, Jayantha Ratnayake, Paul Delmar, Athula Herath, Philip Jarvis and James Matcham;
Pharmaceutical Statistics, Volume 10, Issue 6, Pages 494-507, November/December 2011
Abstract | Paper+ | Slides

+ Papers available to view from 20th September 2012 to 18th October 2012.

For a flier advertising the event, please click here.
 

Upcoming Events

PSI ToxSIG Webinar: Beyond the looking glass - Interpreting animal welfare & behaviour by monitoring & assessing mice activity data

Analysing continuously collected locomotive activity data to interpret mice welfare and behaviour.

PSI Journal Club: Survival Analysis

Our next journal club features two papers on the topic of Survival Analysis. For each of these published papers there will be a 20 minute presentation by author followed by a 10 minute discussion.

PSI VisSIG Webinar: Rapid Insights to Data

The field of data visualization is the intersection of data journalism, statistics, graphic design, computer science, neuroscience, and cognitive psychology. We will focus on the latter two fields of data visualization as it relates to data visualization: neuroscience and cognitive psychology.

PSI One-Day Meeting: Non-proportional hazards and applications in immuno-oncology

Hear about potential strategies to handle non-proportional hazards and delayed treatment effects from experts in the field.

Latest Jobs

Biostatistician Project Leader

As a statistician in the Biostatistics and Programming Department, you will be responsible for the methodological and statistical aspects of projects in early clinical development in order to optimize the early development plan and ensure its coherence.

Director Biostatistics

By joining our company, in this role you will apply your skills and experience in support of developing scientifically based arguments aiming to provide fair accessibility to our company’s drugs and vaccines making a real difference in patient’s lives.

Director of Statistics

As a Director of Statistics, you will be accountable for guiding statisticians in their work, performing senior review of documentation and output deliveries, providing oversight and advising on best practices approach to statistics for clinical trials.